Dr. Attarha joined the Page Lab in 2018 and has hit the ground running. Driving the development of new assays to look at cancer cell signaling, Sanaz' work aims to develop new assays and tools to decipher the molecular mechanisms of commonly used anti-cancer agents. With a better understanding of how these agents work, we aim to improve on these inhibitors to make more potent and safer drug analogues.